
Share
Bullseye event in Chicago seeks to bridge the gap between healthcare investors and BD leaders, fostering strategic partnerships that drive innovation and profitability in the sector.
On July 23, a new invitation-only event called Bullseye: Targeting Healthier Outcomes & Returns will take place in Chicago. This exclusive gathering is specifically designed for healthcare investors and corporate business development (BD) leaders. The event aims to facilitate meaningful connections and strategic discussions that could lead to healthier outcomes and robust returns in the healthcare tech sector.
Bullseye: Targeting Healthlier Outcomes & Returns represents a significant opportunity for stakeholders in the healthcare industry. By bringing together investors and corporate BD leaders, the event seeks to bridge gaps and foster collaborations that can drive innovation and growth. The healthcare tech market has been expanding rapidly, with global investments reaching $14.6 billion in 2022, according to CB Insights. This trend underscores the importance of aligning financial and strategic interests.
The event's focus on healthier outcomes is particularly relevant given the ongoing challenges in the healthcare sector, including rising costs and the need for more efficient care delivery models. By targeting these issues, Bullseye aims to identify and support solutions that can make a tangible difference in patient care while generating sustainable returns for investors.

For investors, Bullseye offers a unique platform to gain insights into emerging trends and technologies in healthcare. The event will feature presentations from leading experts, roundtable discussions, and networking opportunities that can help identify promising investment opportunities. Given the sector's complexity, such events are crucial for staying ahead of market dynamics and making informed decisions.
Corporate BD leaders, on the other hand, can use Bullseye to explore potential partnerships and acquisitions that align with their strategic goals. The healthcare tech landscape is highly fragmented, with numerous startups and established players vying for market share. By engaging with a diverse group of stakeholders, corporate BD leaders can better navigate this competitive environment and secure deals that enhance their company's portfolio.
The event's invitation-only nature ensures a high level of engagement and quality interactions. Participants will have the opportunity to connect with like-minded professionals who are committed to driving positive change in healthcare. For those interested in attending, joining the waitlist is the first step towards securing a spot at this exclusive gathering.
Bullseye: Targeting Healthier Outcomes & Returns presents a valuable opportunity for both investors and corporate BD leaders to align their interests and drive meaningful progress in the healthcare tech sector. As the industry continues to evolve, events like Bullseye will play a crucial role in shaping the future of healthcare innovation and investment.
Tags
Original Sources
corporate business development Coverage - MedCity News
↗ https://medcitynews.com/tag/corporate-business-development
About the author
Marcus began tracking AI's market implications in 2016, noticing AI-related patent filings accelerating ahead of earnings upgrades before most of the sell-side had caught on. A former fixed-income quantitative analyst, he spent two decades building models that priced risk across emerging markets before pivoting to cover the economic impact of AI full-time. His writing translates opaque technical developments into clear risk/reward terms — and he's rarely diplomatic about the gap between AI valuations and underlying fundamentals. He believes most market participants still underestimate AI's long-run deflationary effect on knowledge work.
More from The Analyst →This Week's Edition
14 May 2026
133 articles
Related Articles
Related Articles
More Stories